FBRX
$26.44
Forte Biosciences, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and aut...
Recent News
Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know
Forte Biosciences (FBRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
We Think Forte Biosciences (NASDAQ:FBRX) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Forte Biosciences...
Chief Financial Officer of Forte Biosciences Picks Up 30% More Stock
Investors who take an interest in Forte Biosciences, Inc. ( NASDAQ:FBRX ) should definitely note that the Chief...
Positive week for Forte Biosciences, Inc. (NASDAQ:FBRX) institutional investors who lost 1.7% over the past year
Key Insights Significantly high institutional ownership implies Forte Biosciences' stock price is sensitive to their...
We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...